Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)
Common Stock
Additional Paid-in Capital
Deficit Accumulated During the Development Stage
Total
Beginning Balance, Amount at Dec. 31, 2012 $ 143,668 $ 79,340,666 $ (82,381,854) $ (2,897,520)
Beginning Balance, Shares at Dec. 31, 2012 143,667,570      
Common stock issued upon exercise of warrants, net, Amount 19,937 5,681,202    5,701,139
Common stock issued upon exercise of warrants, net, Shares 19,937,130      
Common stock issued for services, Amount 50 48,950    49,000
Common stock issued for services, Shares 50,000     50,000
Fair value of options and warrants issued as compensation    870,369    870,369
Fair value of warrants issued to settle payables    129,622    129,622
Fair value of warrants issued to consultants    52,361    52,361
Net loss     (338,150) (338,150)
Ending Balance, Amount at Jun. 30, 2013 $ 163,655 $ 86,123,170 $ (82,720,004) $ 3,566,821
Ending Balance, Shares at Jun. 30, 2013 163,654,700